In hepatocellular carcinoma (HCC), METTL3 was SUMOylated by a small ubiquitin-like modifier SUMO1, which in turn facilitated the oncogenic function of METTL3 [65]. The gene discussed is SUMO1; the disease is hepatocellular carcinoma.